Leonard Reyno

2.3k total citations
46 papers, 1.6k citations indexed

About

Leonard Reyno is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leonard Reyno has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leonard Reyno's work include Prostate Cancer Treatment and Research (11 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Palliative Care and End-of-Life Issues (4 papers). Leonard Reyno is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Palliative Care and End-of-Life Issues (4 papers). Leonard Reyno collaborates with scholars based in United States, Canada and France. Leonard Reyno's co-authors include Mario A. Eisenberger, Merrill J. Egorin, Victoria J. Sinibaldi, Malcolm J. Moore, Peter Venner, Timothy J. Whelan, Eric Winquist, R. Sridhara, D. Scott Ernst and K.N. Chi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Leonard Reyno

46 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Leonard Reyno 694 503 332 214 204 46 1.6k
Denis Schallier 768 1.1× 740 1.5× 393 1.2× 117 0.5× 137 0.7× 71 1.6k
Ken Marumo 370 0.5× 708 1.4× 673 2.0× 269 1.3× 111 0.5× 82 2.1k
Charles C. Williams 1.0k 1.5× 925 1.8× 662 2.0× 201 0.9× 126 0.6× 83 2.1k
Paul Wheatley‐Price 1.1k 1.6× 978 1.9× 385 1.2× 309 1.4× 142 0.7× 133 2.0k
Αngelos Koutras 1.6k 2.4× 543 1.1× 588 1.8× 390 1.8× 88 0.4× 132 2.5k
P. Hupperets 629 0.9× 266 0.5× 328 1.0× 340 1.6× 104 0.5× 40 1.4k
Cheryl Ho 1.1k 1.6× 1.0k 2.0× 411 1.2× 227 1.1× 94 0.5× 145 1.9k
M. Moriarty 815 1.2× 467 0.9× 456 1.4× 232 1.1× 98 0.5× 60 1.8k
Vernon Harvey 1.3k 1.9× 357 0.7× 258 0.8× 489 2.3× 138 0.7× 44 1.8k
Camilla Qvortrup 1.1k 1.6× 374 0.7× 286 0.9× 249 1.2× 79 0.4× 86 1.6k

Countries citing papers authored by Leonard Reyno

Since Specialization
Citations

This map shows the geographic impact of Leonard Reyno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Reyno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Reyno more than expected).

Fields of papers citing papers by Leonard Reyno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard Reyno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Reyno. The network helps show where Leonard Reyno may publish in the future.

Co-authorship network of co-authors of Leonard Reyno

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard Reyno. A scholar is included among the top collaborators of Leonard Reyno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard Reyno. Leonard Reyno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vieito, María, Ezra Y. Rosen, Jordi Rodón, et al.. (2024). 612O Preliminary results from a phase I study of CFT1946, a novel BIDAC degrader in mutant BRAF V600 solid tumors. Annals of Oncology. 35. S490–S491. 3 indexed citations
2.
Jahchan, Nadine S., Adriana M. Mujal, Joshua L. Pollack, et al.. (2019). Tuning the Tumor Myeloid Microenvironment to Fight Cancer. Frontiers in Immunology. 10. 1611–1611. 91 indexed citations
3.
McHugh, Deaglan Joseph, Mario A. Eisenberger, Elisabeth I. Heath, et al.. (2019). A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer. Investigational New Drugs. 37(5). 1052–1060. 19 indexed citations
4.
Thompson, John A., Robert J. Motzer, Ana M. Molina, et al.. (2018). Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell Carcinomas. Clinical Cancer Research. 24(18). 4399–4406. 48 indexed citations
5.
Wolpin, Brian M., Eileen M. O’Reilly, Yoo-Joung Ko, et al.. (2013). Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer. Annals of Oncology. 24(7). 1792–1801. 29 indexed citations
6.
Liu, Jianhua, Dongsheng Tu, Janet Dancey, et al.. (2006). Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19. Breast Cancer Research and Treatment. 100(3). 263–271. 30 indexed citations
7.
Crooks, Dauna, Timothy J. Whelan, Leonard Reyno, et al.. (2004). The Initial Health Assessment: an intervention to identify the supportive care needs of cancer patients. Supportive Care in Cancer. 12(1). 19–24. 21 indexed citations
8.
Whelan, Timothy J., Carol Sawka, Mark Levine, et al.. (2003). Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 95(8). 581–587. 185 indexed citations
9.
Miller, Wilson H., Leonard Reyno, Gordon Loewen, et al.. (2000). A phase I-II study of 9-cis retinoic acid and interferon-α2b in patients with advanced renal-cell carcinoma: An NCIC Clinical Trials Group study. Annals of Oncology. 11(11). 1387–1389. 12 indexed citations
10.
Zaza, Christine, Leonard Reyno, & Dwight E. Moulin. (2000). The Multidimensional Pain Inventory profiles in patients with chronic cancer-related pain: an examination of generalizability. Pain. 87(1). 75–82. 20 indexed citations
11.
Whelan, Timothy J., et al.. (1999). Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer. Patient Education and Counseling. 37(3). 283–291. 23 indexed citations
12.
Zaza, Christine, Scott Sellick, Andy Willan, Leonard Reyno, & George P. Browman. (1999). Health care professionals’ familiarity with non-pharmacological strategies for managing cancer pain. Psycho-Oncology. 8(2). 99–111. 18 indexed citations
13.
Reyno, Leonard, Merrill J. Egorin, Mario A. Eisenberger, et al.. (1995). Development and validation of a pharmacokinetically based fixed dosing scheme for suramin.. Journal of Clinical Oncology. 13(9). 2187–2195. 47 indexed citations
14.
Erkmen, Kadir, Merrill J. Egorin, Leonard Reyno, Robert D. Morgan, & James H. Doroshow. (1995). Effects of storage on the binding of carboplatin to plasma proteins. Cancer Chemotherapy and Pharmacology. 35(3). 254–256. 28 indexed citations
15.
Eisenberger, Mario A., Victoria J. Sinibaldi, Leonard Reyno, et al.. (1995). Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer.. Journal of Clinical Oncology. 13(9). 2174–2186. 66 indexed citations
16.
Sridhara, R N, Mario A. Eisenberger, Victoria J. Sinibaldi, Leonard Reyno, & Merrill J. Egorin. (1995). Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy.. Journal of Clinical Oncology. 13(12). 2944–2953. 76 indexed citations
17.
Eisenberger, Mario A. & Leonard Reyno. (1994). Suramin. Cancer Treatment Reviews. 20(3). 259–273. 25 indexed citations
18.
Jodrell, Duncan I., Leonard Reyno, R. Sridhara, et al.. (1994). Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer.. Journal of Clinical Oncology. 12(1). 166–175. 42 indexed citations
19.
Reyno, Leonard, Merrill J. Egorin, Renzo Canetta, et al.. (1993). Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer.. Journal of Clinical Oncology. 11(6). 1156–1164. 27 indexed citations
20.
Reyno, Leonard, et al.. (1993). Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer. European Journal of Cancer. 29(1). 21–23. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denis Schallier Breakdown of academic impact, for papers by Ken Marumo Breakdown of academic impact, for papers by Charles C. Williams Breakdown of academic impact, for papers by Paul Wheatley‐Price Breakdown of academic impact, for papers by Αngelos Koutras Breakdown of academic impact, for papers by P. Hupperets Breakdown of academic impact, for papers by Cheryl Ho Breakdown of academic impact, for papers by M. Moriarty Breakdown of academic impact, for papers by Vernon Harvey Breakdown of academic impact, for papers by Camilla Qvortrup
Rankless by CCL
2026